Innovassynth Investments Ltd

📊 Innovassynth Technologies Announces ₹69.65 Crore Rights Issue

- Projected revenue growth from ₹10,000 lakhs in FY2026 to ₹22,500 lakhs in FY2027

- Total income from operations for Q3 FY2026 was ₹2,207.78 lakhs

- Net loss after tax of ₹779.92 lakhs for Q3 FY2026

- Basic and diluted EPS were negative at ₹(1.03) for Q3 FY2026

- Rights issue of up to 17,411,380 equity shares at ₹40 per share, totaling ₹69.6455 crores

- Issue ratio: 3 rights equity shares for every 13 fully paid-up equity shares held as of April 29, 2026

- Net proceeds of ₹6,882.11 lakhs will be used to prepay a ₹4,400 lakhs ICICI Bank Term Loan, augment working capital by ₹850 lakhs, and for general corporate purposes

- Company operates in Life Sciences, Specialty Chemicals, and Custom Research, Development and Manufacturing (CRDMO)

- Manufacturing facilities in Khopoli and R&D in Pune

- Major shareholders include Viren Rajan Raheja and Akshay Rajan Raheja, each holding 24.86% of equity shares